North America Forensic Genomics Market Size, Share & Industry Trends Analysis Report By Application (Criminal Testing, Paternity & Familial Testing), By Product (Kits & Consumables, Analyzers & Sequencers and Software), By Method, By Country and Growth Fo

North America Forensic Genomics Market Size, Share & Industry Trends Analysis Report By Application (Criminal Testing, Paternity & Familial Testing), By Product (Kits & Consumables, Analyzers & Sequencers and Software), By Method, By Country and Growth Forecast, 2022 - 2028

The North America Forensic Genomics Market would witness market growth of 13.9% CAGR during the forecast period (2022-2028).

The first draft of the human genome sequence was produced by the ten-year, multibillion-dollar Human Genome Project (HGP). This draft genome marked the start of a breakthrough in the biomedical sciences, with a concentration on studies into human evolution as well as medical prognostics, diagnostics, and medication therapies.

The usefulness of being able to sequence a full human genome has exceeded all aspirations in the domain of forensic human identification. Since the first human genome sequence was completed two decades ago, desktop massively parallel sequencing (MPS) machines have made sequencing technology more accessible.

The once-impossible aim of sequencing the complete human genome is feasible owing to MPS's improving user-friendliness and robustness, as well as the sharp decline in sequencing times and costs. With these capabilities, whole genome sequencing from biological evidence discovered at a scene of the crime is now a practical endeavor for solving crimes and generating investigative leads.

Numerous forensic science fields, including genome sequencing, are evolving in the US. To aid in criminal investigations, new methods are being tested, developed, and put into use. Investigators frequently encounter problems with the veracity and accuracy of both modern and traditional approaches. Disaster victim identification, criminal casework, missing person identification, DNA database administration, mtDNA analysis, and STR and SNP sequencing are a few of the uses.

The US market dominated the North America Forensic Genomics Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $285.2 Million by 2028.The Canada market is poised to grow at a CAGR of 16.5% during (2022 - 2028). Additionally, The Mexico market would showcase a CAGR of 15.4% during (2022 - 2028).

Based on Application, the market is segmented into Criminal Testing, Paternity & Familial Testing and Others. Based on Product, the market is segmented into Kits & Consumables, Analyzers & Sequencers and Software. Based on Method, the market is segmented into Capillary Electrophoresis, Next-generation Sequencing and PCR Amplification. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include General Electric (GE) Co. (GE Healthcare), Eurofins Scientific Group (Eurofins Discovery), Gene by Gene, Ltd., Verogen, Inc., Agilent Technologies, Inc., Illumina, Inc., Neogen Corporation, and Thermo Fisher Scientific, Inc.

Scope of the Study

Market Segments covered in the Report:

By Application

  • Criminal Testing
  • Paternity & Familial Testing
  • Others
By Product
  • Kits & Consumables
  • Analyzers & Sequencers


Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Forensic Genomics Market, by Application
1.4.2 North America Forensic Genomics Market, by Product
1.4.3 North America Forensic Genomics Market, by Method
1.4.4 North America Forensic Genomics Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
Chapter 4. North America Forensic Genomics Market by Application
4.1 North America Criminal Testing Market by Country
4.2 North America Paternity & Familial Testing Market by Country
4.3 North America Others Market by Country
Chapter 5. North America Forensic Genomics Market by Product
5.1 North America Kits & Consumables Market by Country
5.2 North America Analyzers & Sequencers Market by Country
5.3 North America Software Market by Country
Chapter 6. North America Forensic Genomics Market by Method
6.1 North America Capillary Electrophoresis Market by Country
6.2 North America Next-generation Sequencing Market by Country
6.3 North America PCR Amplification Market by Country
Chapter 7. North America Forensic Genomics Market by Country
7.1 US Forensic Genomics Market
7.1.1 US Forensic Genomics Market by Application
7.1.2 US Forensic Genomics Market by Product
7.1.3 US Forensic Genomics Market by Method
7.2 Canada Forensic Genomics Market
7.2.1 Canada Forensic Genomics Market by Application
7.2.2 Canada Forensic Genomics Market by Product
7.2.3 Canada Forensic Genomics Market by Method
7.3 Mexico Forensic Genomics Market
7.3.1 Mexico Forensic Genomics Market by Application
7.3.2 Mexico Forensic Genomics Market by Product
7.3.3 Mexico Forensic Genomics Market by Method
7.4 Rest of North America Forensic Genomics Market
7.4.1 Rest of North America Forensic Genomics Market by Application
7.4.2 Rest of North America Forensic Genomics Market by Product
7.4.3 Rest of North America Forensic Genomics Market by Method
Chapter 8. Company Profiles
8.1 General Electric (GE) Co. (GE Healthcare)
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.1.5 SWOT Analysis
8.2 Thermo Fisher Scientific, Inc.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.5 Recent strategies and developments:
8.2.5.1 Partnerships, Collaborations, and Agreements:
8.2.5.2 Product Launches and Product Expansions:
8.2.5.3 Acquisition and Mergers:
8.2.6 SWOT Analysis
8.3 Agilent Technologies, Inc.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Acquisition and Mergers:
8.4 Illumina, Inc.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Regional Analysis
8.4.4 Research & Development Expense
8.4.5 Recent strategies and developments:
8.4.5.1 Partnerships, Collaborations, and Agreements:
8.5 Neogen Corporation
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expenses
8.6 Eurofins Scientific Group (Eurofins Discovery)
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Regional Analysis
8.6.4 Recent strategies and developments:
8.6.4.1 Partnerships, Collaborations, and Agreements:
8.7 Gene by Gene, Ltd.
8.7.1 Company Overview
8.7.2 Recent strategies and developments:
8.7.2.1 Partnerships, Collaborations, and Agreements:
8.8 Verogen, Inc.
8.8.1 Company Overview
8.8.2 Recent strategies and developments:
8.8.2.1 Partnerships, Collaborations, and Agreements:
8.8.2.2 Product Launches and Product Expansions:
8.8.2.3 Acquisition and Mergers:

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings